CY1113968T1 - Therapeutic Use of Farnesyl Transfer Suspensions - Google Patents

Therapeutic Use of Farnesyl Transfer Suspensions

Info

Publication number
CY1113968T1
CY1113968T1 CY20131100352T CY131100352T CY1113968T1 CY 1113968 T1 CY1113968 T1 CY 1113968T1 CY 20131100352 T CY20131100352 T CY 20131100352T CY 131100352 T CY131100352 T CY 131100352T CY 1113968 T1 CY1113968 T1 CY 1113968T1
Authority
CY
Cyprus
Prior art keywords
therapeutic use
farnesyl transfer
suspensions
transfer suspensions
farnesyl
Prior art date
Application number
CY20131100352T
Other languages
Greek (el)
Inventor
Anne Fourie
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05851365A external-priority patent/EP1815247B1/en
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1113968T1 publication Critical patent/CY1113968T1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Περιγράφεται η θεραπευτική χρήση αναστολέων φαρνεζυλτρανσφεράσης (π.χ., τιπιφαρνίμπης) για την θεραπεία σηψαιμίας. Επίσης, περιγράφονται μέθοδοι χρήσιμοι για να παρακολουθείται η αποτελεσματικότητα μιας τέτοιας θεραπείας.The therapeutic use of farnesyltransferase inhibitors (e.g., typhifarnib) for the treatment of septicemia is described. Methods are also described to monitor the effectiveness of such treatment.

CY20131100352T 2004-11-05 2013-04-29 Therapeutic Use of Farnesyl Transfer Suspensions CY1113968T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62520404A 2004-11-05 2004-11-05
US70807505A 2005-08-12 2005-08-12
EP05851365A EP1815247B1 (en) 2004-11-05 2005-11-02 Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof

Publications (1)

Publication Number Publication Date
CY1113968T1 true CY1113968T1 (en) 2016-07-27

Family

ID=58448994

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20131100352T CY1113968T1 (en) 2004-11-05 2013-04-29 Therapeutic Use of Farnesyl Transfer Suspensions
CY20141100974T CY1116656T1 (en) 2004-11-05 2014-11-25 METHODS OF MONITORING THE EFFECTIVENESS OF FARNEZYL TRANSFER SUSPENSIONS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20141100974T CY1116656T1 (en) 2004-11-05 2014-11-25 METHODS OF MONITORING THE EFFECTIVENESS OF FARNEZYL TRANSFER SUSPENSIONS

Country Status (1)

Country Link
CY (2) CY1113968T1 (en)

Also Published As

Publication number Publication date
CY1116656T1 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
CY1122522T1 (en) META ARSENICODE SODIUM FOR USE IN THE MANAGEMENT OF MULTIPLE MYELOMA
CY1121135T1 (en) SUBSTITUTED FOUR-CYCLINES COMPOUNDS FOR THE TREATMENT OF INFLAMMATIVE SKIN DISORDERS
HK1110651A1 (en) Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof
EA200900959A1 (en) MEK INHIBITORS
CY1115350T1 (en) USE OF DPP SUSPENSIONS IV
ATE461923T1 (en) SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBONIC ACID AMIDES ARE EFFECTIVE PARP INHIBITORS
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
NO20083002L (en) Method for using CD40 binding compounds
BR0312785A (en) Treatment of Tnf-related disorders (alpha)
EA200602221A1 (en) NEW APPLICATION OF PEPTIDE CONNECTIONS FOR THE TREATMENT OF PAIN IN TRIGEMINAL NEURALGIA
EA200702048A1 (en) PHARMACOKINETICALLY IMPROVED COMPOUNDS
EA201070247A1 (en) PROTEAS INHIBITORS
EA201100505A1 (en) ORGANIC CONNECTIONS FOR USE FOR THE TREATMENT OF BACTERIAL INFECTIONS
EA200970738A1 (en) AKT ACTIVITY INHIBITORS
BRPI0410711A (en) new compounds
CY1107688T1 (en) BICYCLE PYRROLIDINE COMPOUNDS
NO20072092L (en) sulfonamide
NO20054494L (en) Peptidvektorer
GT200600494A (en) SPIROCYCLE DERIVATIVES
EA200801413A1 (en) HETEROCYCLIC CETR INHIBITORS
ECSP045131A (en) CYOSOSOLIC PHOSPHOLIPASE A2 INHIBITORS
DE602004014190D1 (en) 2- (1H-INDOLYLSULFANYL) -BENZYLAMINE DERIVATIVES AS SSRI
DK1608655T3 (en) Pyrroloimidazole derivatives, their preparation, pharmaceutical compositions containing them and their use as nootropic agents
CY1107562T1 (en) USE OF N- (2-Aryl-Propionyl) -suclfonamides for the treatment of traumatic brain injury
EA200701584A1 (en) ORGANIC COMPOUNDS APPLICABLE FOR THE TREATMENT OF ALZHEIMER'S DISEASE, THEIR APPLICATION AND METHOD OF OBTAINING